Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Waits

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 1, 2022
Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trialAlexander Waits, Jau-Yuan Chen, Wei-Hong Cheng, et al.
Journal of Exposure Science & Environmental Epidemiology|July 16, 2021
Exposome of attention deficit hyperactivity disorder in Taiwanese children: exploring risks of endocrine-disrupting chemicalsAlexander Waits, Chia-Huang Chang, Ching-Jung Yu, et al.
Frontiers in Public Health|April 25, 2025
Socioeconomic status in the association between use of personal care products and exposure to endocrine-disrupting chemicals in pregnant Taiwanese womenAlexander Waits, Chia-Huang Chang, Yu-Fang Huang, et al.
Vaccine|April 20, 2023
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trialLila Estephan, Ying-Chin Lin, Yi-Tsung Lin, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 1, 2022
Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trialAlexander Waits, Jau-Yuan Chen, Wei-Hong Cheng, et al.
Journal of Exposure Science & Environmental Epidemiology|July 16, 2021
Exposome of attention deficit hyperactivity disorder in Taiwanese children: exploring risks of endocrine-disrupting chemicalsAlexander Waits, Chia-Huang Chang, Ching-Jung Yu, et al.
Frontiers in Public Health|April 25, 2025
Socioeconomic status in the association between use of personal care products and exposure to endocrine-disrupting chemicals in pregnant Taiwanese womenAlexander Waits, Chia-Huang Chang, Yu-Fang Huang, et al.
Vaccine|April 20, 2023
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trialLila Estephan, Ying-Chin Lin, Yi-Tsung Lin, et al.
Pageof 3